Another study (Arora et al., 2020) investigated the use of GLUT1 to transport brain‐derived neurotrophic factor (BDNF) into the brain as a potential treatment for Alzheimer's disease. Here, SLC2A1 is linked to early-onset autosomal dominant Alzheimer disease.